MedPass has helped more than 1,000 companies, from start ups to multi-nationals, assisting our clients in the clinical development and market access of their emerging technology.
We have experience across a broad range of therapeutic areas, and all phases of medical device development from preclinical to the post marketing phase. We are particularly well known for our strong contribution to companies developing emerging technologies.
Since 1991, MedPass has been a part of successful development of hundreds of innovative technologies from the first fully functional cervical disc replacement in the late 1990’s through dedicated interventional neuroradiology devices to treat stroke in the early 2000’s to the first CE Marking of a transcatheter aortic valve.
Successful operations are based on teamwork and continuing attention to detail, minimizing client costs and offering total accountability. We arrange tailored service to meet our client specific objectives.